FDA 483 - StageBio - September 03, 2021

StageBio, a non-clinical laboratory in Frederick, MD, was inspected and received two observations. The inspection revealed the use of expired reagents in studies and the availability of expired reagents for use. Additionally, the firm lacked adequate written standard operating procedures for tracking study materials and controlling access to storage areas, which could impact data quality and integrity.